A carregar...
JAK1抑制剂SHR0302和芦可替尼对骨髓增殖性肿瘤SET2细胞系和原代细胞增殖抑制和抗炎作用机制的研究
OBJECTIVE: To explore the effects and molecular mechanism of the selective JAK1inhibitor SHR0302 and Ruxolitinib on myeloproliterative neoplasms（MPN）cell line SET2 and primary cells in vitro. METHODS: Cell proliferation was detected by CCK8 kit. Colony forming experiment was conducted to evaluate er...
Na minha lista:
| Publicado no: | Zhonghua Xue Ye Xue Za Zhi |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Editorial office of Chinese Journal of Hematology
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7342687/ https://ncbi.nlm.nih.gov/pubmed/32023730 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.12.006 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|